Literature DB >> 10071347

Budd-Chiari syndrome associated with factor V leiden mutation: a report of 6 patients.

R Hoffman1, A Nimer, N Lanir, B Brenner, Y Baruch.   

Abstract

Budd-Chiari syndrome is characterized by hepatic venous outflow obstruction. Although myeloproliferative disorders are usually responsible for this severe thrombotic disorder, deficiency or dysfunction of the natural anticoagulants can be involved. Resistance to activated protein C caused by factor V Leiden mutation has been recently identified as a major cause of thrombophilia. We report 6 patients with Budd-Chiari syndrome associated with factor V Leiden mutation combined with another acquired thrombophilic state (myeloproliferative disorder and lupus anticoagulant in 3 cases) and without another thrombophilic disorder in the other 3 cases. We conclude that factor V Leiden mutation should be evaluated in any case of hepatic vein occlusion because the prevalence of this mutation in the general population is high.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10071347     DOI: 10.1002/lt.500050211

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  3 in total

1.  Budd-Chiari syndrome associated with visceral leishmaniasis and factor V Leiden mutation.

Authors:  Emel Gürkan; Cağatay Unsal; Fikri Başlamişli; Didem Arslan
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

2.  Budd-Chiari syndrome: long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt.

Authors:  Alexandra Zahn; Daniel Gotthardt; Karl Heinz Weiss; Götz Richter; Jan Schmidt; Wolfgang Stremmel; Peter Sauer
Journal:  BMC Gastroenterol       Date:  2010-03-01       Impact factor: 3.067

3.  Budd-Chiari Syndrome.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.